Abstract Library

#1316 Validation of Lysyl Oxidase-Like 2 (LOXL2) as Prognostic Marker for Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NET) Using an Independent Cohort.

Introduction: LOXL2 is a key protein to epithelial to mesenchymal transition. We showed LOXL2 has a role as a prognostic marker in 115 GEP-NET cases (training cohort (TC)).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Barriuso J, Benavent M, Lamarca A, Bernal E, Guerra-Pastrian L,

Keywords: LOXL2,

#966 Evaluation of Lysyl Oxidase-Like-2 (LOXL2) Expression by Immunohistochemistry (IHC) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET): A Retrospective Analysis and Comparison with PTEN

Introduction: A better understanding of the relationship between the stroma and the cancer cells of this group of malignancies remains a challenge. LOXL2 is an enzyme that contributes to the synthesis and stabilization of the cellular matrix and plays a role in angiogenesis.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Barriuso J

Authors: Barriuso J, Bernal E, Pastrian L, Alvárez-Escolá C, Martinez J,

Keywords: LOXL2, GEP-NET,